Back to Results
First PageMeta Content
Medicine / AstraZeneca / Influenza vaccine / Flu pandemic / Influenza A virus subtype H5N1 / Virology / MedImmune / FluMist / Virus / Vaccines / Influenza / Vaccination


FLUVACC A new vaccine against influenza to be taken by nasal spray
Add to Reading List

Document Date: 2011-05-02 05:09:01

Open Document

File Size: 522,69 KB

Share Result on Facebook

City

Vienna / /

Company

AVIR Green Hills Biotechnology AG / Virology Influenza Diagnostics / /

Currency

EUR / /

Event

Product Issues / FDA Phase / /

Facility

Robert Koch Institute / DE Influenza B Contract Manufacturer AVIR Green Hills Biotechnology Institute of Influenza / /

MedicalCondition

FLUVACC Virus Infections / influenza / /

Organization

Robert Koch Institute / Contract Manufacturer AVIR Green Hills Biotechnology Institute of Influenza / European Union / /

Person

Thomas Muster / /

Position

CEO / /

Product

Interferon induction Media / FLUVACC / /

Technology

antibodies / /

SocialTag